The GeneSight® Test: A Personalized Approach to Helping Patients Get Their Lives Back
Finding the right medication for patients with neuropsychiatric disorders can be challenging and result in a long period of trial and error. The GeneSight test analyzes a patient’s genes and gives healthcare providers information to help them select the medicines that are more likely to work for individual patients. The GeneSight test provides answers that can lead to a personalized treatment plan and faster response and remission for patients.
The GeneSight test meets a significant unmet clinical need and is the leading product for psychotropic drug selection. It is used by healthcare providers to help patients who are affected by neuropsychiatric conditions including depression, anxiety, ADHD, bipolar disorder, schizophrenia, post-traumatic stress disorder (PTSD) and other behavioral health conditions, as well as chronic pain. Powered by CPGx™, the GeneSight test uses a proprietary combinatorial pharmacogenomics technology that analyzes how an individual’s genetic variations affect his or her response to medications and provides an actionable, easy to interpret report that is available within 36 hours. The test is clinically proven to enhance medication selection, helping healthcare providers get their patients on the right medication faster.